Moonlake Immunotherapeutics (MLTX)Deep Track Capital, LP opened a new position $60.8M

4.61M

Shares reported

1.1%

Disclosed portfolio weight

$60.8M

Reported value

Holdings as of

Dec 31, 2025

Filed

Feb 13, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

What came next

1. Feb 18, 2026Company filing · Form 8-K · Material agreement, ResultsChanged a top executive or board member, and signed an important agreement (and 4 more items)“On February 18, 2026, Simon Sturge notified the Board of Directors (the “Board”) of the Company of his intent to resign as a member of the Board, effective as of February 28, 2026 (the “Effective Date”).”
2. May 10, 2026Company filing · Form 8-K · Results, Reg FDReported its results, and shared information with investors
3. May 22, 2026Company filing · Form 8-K · Material agreementSigned an important agreement
4. Jun 4, 2026Company filing · Form 8-K · Executive change, Shareholder voteChanged a top executive or board member, and held a shareholder vote“Departure of Director or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.”

How to read SEC Form 13F-HR

Form 13F is the quarterly report in which investment managers that oversee $100 million or more list the US-listed stocks and some other securities they held on the last day of the quarter.

Full guide: What is an SEC Form 13F?

What else is on file for Moonlake Immunotherapeutics

For Moonlake Immunotherapeutics, OQRO holds 4 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its MLTX page.

How this filing works

• SEC Form 13F

Other disclosures at Moonlake Immunotherapeutics

• SEC Form 13F-HRAug 14, 2026
• SEC Form 13F-HRAug 14, 2026
• SEC Form 13F-HRAug 14, 2026
• SEC Form 13F-HRAug 14, 2026
• SEC Form 13F-HRMay 15, 2026
• SEC Form 13F-HRMay 15, 2026

Everything OQRO holds on this company is on its MLTX page.